| H |
|
HAEMATE HS IN PATIENTS WITH SEVERE BLEEDING UNDERGOING VALVE REPLACEMENT DUE TO AORTIC STENOSIS (HAVAS-STUDY)
|
| Zotz R.B., Sucker C., Scharf R.E., Jurs M., Knaub S., Boeken P., Kurt M., Gams E., Feindt P. |
| |
|
HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY
|
| Dragani A., Marchesini E., Carloni M., Oliovecchio E., Ferrante F., Iuliani O., Agnelli G., Iorio A. |
| |
|
HAEMOPHILIA TREATMENT IN SERBIA FROM 2000 TO 2006 HOW TO REACH ONE UNIT PER CAPITA IN LOW ECONOMIC CAPACITY COUNTRY
|
| Mikovic D., Jankovic G., Rakic L., Kovac M., Maslac A. |
| |
|
HAEMORRHAGES SYMPTOMS IN GIRL WITH FACTOR XII SEVERE DEFICIENCY
|
| Vdovin V.V., Svirin P., Shiller E., Yatsenko E., Soscov G. |
| |
|
HAEMOSTASIS AND FIBRINOLYSIS AFTER EXPERIMENTAL AUDIOGENIC SEIZURES/
|
| Lyutova L.V., Koshelev V.B., Karabasova M.A. |
| |
|
HAEMOSTASIS DISTURBANCES IN TYPE I AND II DIABETES MELLITUS
|
| Van Dreden P., Rousseau A., Exner T., Vasse M., Ozenne G., Woodhams B.J. |
| |
|
HAEMOSTATIC AND CYTOKINE CHANGES IN GESTATIONAL AND PREGESTATIONAL DIABETES MELLITUS
|
| Abdel Gadir A.M., Khashoggi T.Y., Habib F.M. |
| |
|
HAEMOSTATIC AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS: EFFECT OF TUMOR NECROSIS FACTOR ALPHA BLOCKADE
|
| Cugno M., Ingegnoli F., Favalli E., Soldi A., Griffini S., Bonanni E., Galbiati V., Fantini F. |
| |
|
HAEMOSTATIC PROFILE OF FULL TERM HEALTHY SMALL FOR GESTATIONAL AGE (SGA) NEONATES
|
| Mitsiakos G., Papaioannou G., Giougi E., Chatziioannidis H., Papadakis E., Karagianni P., Athanasiou M., Athanassiadou F., Nikolaides N. |
| |
|
HAEMOSTATS BONDED WITHIN INTERMOLECULAR COMPLEXES AND THEIR EFFECT ON PLATELET COUNT DECREASE IN ANTICOAGULATED BLOOD
|
| Pecka M. |
| |
|
HAEMOTHORAX IN A BOY WITH SEVERE HAEMOPHILIA AND FACTOR VIII INHIBITOR
|
| Laguna P., Klukowska A., Brzewski M., Matysiak M. |
| |
|
HANDHELD COMPUTERS: AN EFFECTIVE SYSTEM TO RECORD HOME-THERAPY DATA OF PATIENTS WITH HAEMOPHILIA
|
| Nunez R., Perez N.F., Brasser M., Kimmet A., Perez Garrido R. |
| |
|
HAPLOTYPES IN THE PROMOTER REGION OF BETA-FIBRINOGEN GENE AND THEIR RELATIONSHIP TO ISCHEMIC STROKE IN HAINAN HAN POPULATION IN CHINA
|
| Cai W., Xing H.H.X. |
| |
|
HAPLOTYPES OF THE C-REACTIVE PROTEIN GENE, PLASMA CRP LEVELS AND THE RISK OF MYOCARDIAL INFARCTION IN MEN
|
| de Visser M.C.H., Paffen E., Vos H.L., Bertina R.M., Doggen C.J.M., Rosendaal F.R. |
| |
|
HAPLOTYPES OF THE PROTEIN Z GENE ASSOCIATED WITH SYMPTOMATIC THROMBOEMBOLISM IN CHILDREN
|
| Nowak-Gottl U., Thedieck S., Seehafer T., Huge A., Stoll M. |
| |
|
HCAN CHANGES IN HEMOSTATIC PARAMETERS EXPLAIN THE INCREASED INCIDENCE OF DVT IN ELDERLY ?
|
| Mahé I., Boulanger C., Bal dit Sollier C., Simoneau G., Bergmann J., Tedgui A., Drouet L. |
| |
|
HEART-TYPE FATTY ACID BINDING PROTEIN IS PREDICTIVE FOR MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
|
| Kruip M.J.H.A., Pelsers M.M.A.L., Troost M.M., Huisman M.V., Nijkeuter M., Glatz J.F.C., Leebeek F.W.G. |
| |
|
HEAT SHOCK PROTEIN 70 (HSP 70) LEVELS AS PROGNOSTIC MARKER OF SEPTIC PATIENTS
|
| Hoffmann U., Klank D., Holzinger T., Liebetrau C., Lang S., Brückmann M., Borggrefe M. |
| |
|
HELICAL COMPUTED TOMOGRAPHY TO ASSESS RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
|
| Becattini C., Vedovati M.C., Duranti M., Grifoni S., Vanni S., Salvi A., Ageno W., Conti S., Pepe G., Agnelli G. |
| |
|
HELICOBACTER PYLORI ERADICATION CAN INDUCE PLATELET RECOVERY IN CHRONIC REFRACTORY IDIOPATHIC THROMBOCYTOPENIC PURPURA
|
| Azarm T., Hoorfar H. |
| |
|
HEMATOPOIETIC STEM CELL LOCALIZATION IN EMBRYONIC VASCULATURE
|
| Dzierzak E.A. |
| |
|
HEME INDUCES TISSUE FACTOR EXPRESSION IN HUMAN LUNG MICROVASCULAR ENDOTHELIAL CELLS: RELATIONSHIP TO CLINICAL HEMOLYTIC STATES
|
| Setty Y.B.N., Gayen-Betal S., Zhang J., Kulkarni S., Stuart M. |
| |
|
HEMODIALYSER MEMBRANES ALLOW FOR REMOVAL OF ARGATROBAN
|
| Krieger D., Geisen U., Is A., Fischer K.G. |
| |
|
HEMODIALYSIS DOWN REGULATES THE INFLAMMATORY MEDIATORS IN PATIENTS WITH END STAGE RENAL DISEASE
|
| Bansal V., Hoppensteadt D., Cunanan J., Bajwa R.S., Patel C., Bick R., Fareed J. |
| |
|
HEMODILUTION CAUSES HYPERCOAGULABILITY
|
| Sinauridze E.I., Bulanov A.Y. |
| |
|
HEMOPHILIA A INHIBITOR AND AUTOIMMUNNEUTROPENIA: CASE REPORT
|
| Heine S.I., Reinhard H., Pindur G., Graf N. |
| |
|
HEMOPHILIA PATIENTS WITH INHIBITORS UNDERGOING MAJOR ORTHOPEDIC SURGERIES: COST-MINIMIZATION ANALYSIS OF ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) AND RECOMBINANT FVIIA
|
| Bonnet P., Yoon B., Ewenstein B., Wong W. |
| |
|
HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION
|
| Sofi F., Bolli P., Marcucci R., Alessandrello Liotta A., Lenti M., Abdihakim A., Mannini L., Abbate R., Gensini G., Prisco D. |
| |
|
HEMORRHAGIC TRANSFORMATION OF ARTERIAL ISCHEMIC STROKE IN CHILDREN
|
| Kirton A., Schechter T., Brandao L., Laughlin S., Chan A., Williams S., MacGregor D., Pontigon A., deVeber G. |
| |
|
HEMOSTASIS AND PREGNANCY: PRELIMINARY STUDY
|
| Aït Chafa-Tadlaoui D., Touchrift C.C.T. |
| |
|
HEMOSTASIS DISORDERS MARKERS IN INTRACRACRANIAL MENONGIOMAS (IM) PATIENTS
|
| Aloeva M.A., Vorobyova E.O., Magalashvili G.E. |
| |
|
HEMOSTASIS IN FACTOR VIII DEFICIENT MICE IS IMPROVED AFTER THE INFUSION OF MONOCYTE-DERIVED MICROPARTICLES
|
| Akram A., Teitel J.M., Freedman J.J., Gross P.L. |
| |
|
HEMOSTATIC CHANGES IN BRAZILIAN SPOTTED FEVER
|
| Alves B.E., Angerami R.N., Annichino-Bizzacchi J.M., Araujo G.S., Castro V., Silva L.J., De Paula E.V. |
| |
|
HEMOSTATIC EFFECTS OF LIPOSOMES CARRYING FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE AND ENCAPSULATING ADENOSINE 5'-DIPHOSPHATE AS A PLATELET SUBSTITUTE
|
| Takeoka S., Okamura Y., Maekawa I., Handa M., Ikeda Y. |
| |
|
HEMOSTATIC EFFECTS OF LIPOSOMES CARRYING FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE AS A PLATELET SUBSTITUTE
|
| Okamura Y., Maekawa I., Handa M., Ikeda Y., Takeoka S. |
| |
|
HEMOSTATIC EXPRESSION OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDREN
|
| Margit S., Ionita H., Bataneant M., Arghirescu S., Mihailov D., Jinca C., Oprisoni A., Stana L. |
| |
|
HEMOSTATIC MARKERS AS PROGNOSTIC FACTORS IN ATRIAL FIBRILLATION. PRELIMINARY RESULTS OF A PROSPECTIVE STUDY
|
| Caruso V., Alberto F., Meschengieser S.S., Vizcaychipi K., Grosso S., Sánchez-Luceros A., Casais P., Hendler M.F., Lazzari M.A. |
| |
|
HEMOSTATIC PROFILE IN PATIENTS WITH PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD): ASSOCIATION TO ANKLE-BRACHIAL INDEX (ABI)
|
| Mota A.P.L., Santos M.E.R.C., Silva F.C.L., Lages G.F.G., Carvalho M.G. |
| |
|
HEMOSTATIC RESPONSES TO RECOMBINANT ACTIVATED FACTOR VII IN THE PRESENCE OF ANTITHROMBIN DEFICIENCY
|
| Szlam F., Taketomi T., Sheppard C., Kempton C.L., Levy J.H., Tanaka K.A. |
| |
|
HEPARANASE INDUCES TFPI EXPRESSION AND EXTRACELLULAR ACCUMULATION IN ENDOTHELIAL AND TUMOR CELLS
|
| Nadir Y., Brenner B., Gingis-Velitski S., Levy-Adam F., Ilan N., Zcharia E., Nadir E., Vlodavsky I. |
| |
|
HEPARANASE MODULATES HEPARINOIDS ANTICOAGULANT ACTIVITIES VIA NON-ENZYMATIC MECHANISMS
|
| Katz B., Muhl L., Zwang E., Ilan N., Herishanu Y., Deutsch V., Naparstek E., Preissner K.T., Vlodavsky I. |
| |
|
HEPARIN AFFINITY CHROMATOGRAPHY AND ADDITIONAL PURIFICATION STEPS EFFECTIVELY ELIMINATE AN EXPERIMENTAL TSE-MODEL AGENT SPIKED INTO FACTOR VIII/VWF PRODUCTION PROCESS
|
| Diez J.M., Caballero S., Gajardo R., Jorquera J.I. |
| |
|
HEPARIN AND BLEEDING HISTORY IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS
|
| Hertfelder H., Seidel H., Alfter K., Kolck U.W., Rott B., Höbert E., Flommersfeld S., v. Kügelgen I., Homann J., Oldenburg J., Molderings G.J. |
| |
|
HEPARIN EYE DROPS ARE EFFECTIVE AS LONG TERM THERAPY FOR LIGNEOUS CONJUNCTIVITIS
|
| Monagle P., Elder J., McConville D., Mitchell S. |
| |
|
HEPARIN INDEPENDENT ACTIVATION OF PLATELETS BY HIT ANTIBODIES. A COMMON OCCURRENCE
|
| Socher I., Kroll H., Sachs U. |
| |
|
HEPARIN INDUCED THROMBOCYTOPENIA: A LIFE THREATENING SYNDROME. THREE YEARS OF EXPERIENCE IN A LARGE GENERAL HOSPITAL
|
| Theodoridis T., El Aly M., Galea V., Karyda A., Kampagianni O., Christopoulou-Kokkinou V. |
| |
|
HEPARIN INDUCED THROMBOCYTOPENIA: COMPLIANCE WITH GUIDELINES IN A LARGE COMMUNITY HOSPITAL
|
| DePaulis A.I., Robinson E.A., Patton W.F. |
| |
|
HEPARIN PROTECTS THE NATIVE CONFORMATION OF ANTITHROMBIN
|
| Ordóñez A., Miñano A., Hernández-Espinosa D., González-Conejero R., Vicente V., Corral J. |
| |
|
HEPARIN TREATMENT INCREASES TYROSINE PHOSPHORYLATION OF PROTEINS IN BREAST CANCER CELLS: DIFFERENCES IN THE EFFECT OF LMWH AND UFH
|
| Razzaq T.M., Scully M.F., Wait R., Kakkar A.K. |
| |
|
HEPARIN-INDUCED PLATELET AGGREGATION DOES NOT PREDICT THE PRESENCE OF ANTI-HEPARIN ANTIBODIES
|
| Streer N.P., Lawson H., James L.B., Owen J. |
| |
|
HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) AND DILATED CARDIOMYOPATHY (DCM) - PARALLELS IN THE PATHOGENESIS OF TWO SEVERE IMMUNE MEDIATED CARDIOVASCULARE DISORDERS
|
| Greinacher A., Staudt A., Eichler P., Trimpert C., Felix S. |
| |
|
HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): A PROSPECTIVE STUDY ON THE INCIDENCE, PLATELET-ACTIVATING CAPACITY AND CLINICAL SIGNIFICANCE OF ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODIES (ANTI-PF4/H ABS) OF THE IGG, IGM, AND IGA CLASS
|
| Greinacher A., Juhl D., Strobel U., Raschke R., Fuerll B., Wessel A., Lubenow N., Eichler P., Warkentin T.E. |
| |
|
HEPARIN-INDUCED THROMBOCYTOPENIA IN A PATIENT WITH POLYCYTEMIA VERA: A THREATENING ASSOCIATION
|
| Kwon M., Rodriguez Huerta A., Pascual C., Perez Rus G., Patrignani N., Muñoz C., Diez Martin J. |
| |
|
HEPARIN-INDUCED THROMBOCYTOPENIA IN CARDIAC SURGERY PATIENTS
|
| Neuffer M., Fischer D., Geisen U., Berchtold-Herz M., Beyersdorf F., Fischer K.G. |
| |
|
HEPATIC TARGETING OF ADENOVIRUS MEDIATED BY COAGULATION FACTOR X
|
| McVey J.H., Waddington S.N., Parker A.L., Lopez-Franco O., Buckley S., Nicklin S.A., Baker A.H. |
| |
|
HEPCIDIN IN HEMODIALYZED AND PERITONEALLY DIALYZED PATIENTS: A LINK BETWEEN ANEMIA AND INFLAMMATION?
|
| Malyszko J., Malyszko J.S., Pawlak K., Mysliwiec M. |
| |
|
HEREDITARY ANGIOEDEMA TYPE III ARE CAUSED BY A GAIN OF FUNCTION MUTATION IN COAGULATION FACTOR XII, WHICH INCREASES VASCULAR PERMEABILITY MEDIATED BY BRADYKININ GENERATION
|
| Muller F., Cichon S., Nothen M., Walter U., Renne T. |
| |
|
HEREDITARY COAGULATION FACTOR XIII DEFICIENCY CAUSED BY A DELETION MUTATION OF F13A GENE
|
| Wu J., Jiao W., Ding Q., Wang X., Xu X., Zheng C. |
| |
|
HEREDITARY DEFICIENCIES OF ANTITHROMBIN, PROTEIN S, AND THE PROTEIN C PATHWAY IN IRANIAN DVT PATIENTS
|
| Ahmadinejad M., Bashash D., Zolfaghari S., Talebian A., Tabatabaii M. |
| |
|
HEREDITARY DYSFUNCTIONAL FACTOR X IS THAT PASSOVOY FACTOR?
|
| Nair S.C., Baidya S., Sukumaran D., Sudhakar V., Srivastava A. |
| |
|
HEREDITARY THROMBOPHILIC DEFECTS IN IRANIAN PATIENTS WITH CEREBRO VASCULAR ACCIDENT
|
| Ahmadinejad M., Bashash D., Zolfaghari S., Talebian A., Tabatabaii M., Dadgar J. |
| |
|
HERITABILITY OF C-REACTIVE PROTEIN AND INTERLEUKIN 6 AMONG THE ASIAN INDIAN POPULATION
|
| Rao V.S., Natesha B.K., Kanjilal S., Mukherjee M., Kakkar V.V. |
| |
|
HERITABILITY OF MEASURES OF CLOT TURBIDITY AND CLOT LYSIS IN THE LEEDS FAMILY STUDY
|
| Carter A.M., Cymbalista C.M., Spector T.D., Grant P.J. |
| |
|
HETEROCLITIN D, A COMPONENT OF PLANTS OF THE KADSURA SPECIES INHIBITS PAF-INDUCED PLATELET AGGREGATION, P-SELECTIN EXPRESSION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION
|
| Wire R., May J.A., Heptinstall S., Chen D., Lu Y., Zhao L. |
| |
|
HETEROGENEITY OF ESSENTIAL THROMBOCYTHEMIA: VARIABLE EXPRESSION OF THE V617F JAK2 MUTATION AND THE PLATELET CD36 LEVEL. NO ASSOCIATION WITH THROMBOTIC MANIFESTATIONS
|
| Darghouth D., Cassinat B., Boval B., Chomienne C., Vicaut E., Rosa J., Bellucci S.A. |
| |
|
HETEROGENEITY OF HPA-3 ALLOANTIBODIES: CONSEQUENCES FOR THE DIAGNOSIS OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
|
| Socher I., Zwingel C., Santoso S., Kroll H. |
| |
|
HETEROGENEITY OF PHENOTYPES IN PATIENTS WITH VON WILLEBRAND DISEASE ASSOCIATED WITH NULL MUTATIONS: AN OBSERVATION IN FAMILIES WITH THREE NOVEL MUTATIONS
|
| Castaman G., Giacomelli S.H., Ghiotto R., Bertoncello K., Bernardi M., Madeo D., Tosetto A., Rodeghiero F. |
| |
|
HETEROGENEITY WITHIN THE PROTEIN CONTENT OF SECRETORY ORGANELLES OF HUMAN PLATELETS
|
| Nurden A.T., Block A., Villeneuve J., Combrié R., Bermeja E., Ripoche J., Nurden P. |
| |
|
HETEROGENEOUS SEQUENCE CHANGES IN THE PROMOTER AND CODING SEQUENCE OF THE FACTOR VIII GENE IDENTIFIED IN 247 FAMILIES FROM THE UK
|
| Theophilus B.D., Guilliatt A.M., Enayat M.S., Williams I.J., Williams M.D., Wilde J.T., Hill F.G.H. |
| |
|
HETEROZYGOUS FIBRINOGEN GAMMA-114 TYR-HIS MUTATION ASSOCIATED WITH RESISTANCE TO TPA-MEDIATED FIBRINOLYSIS AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
|
| Morris T.A., Magana M.M., Marsh J.J., Chiles P.G., DeSantis D.J., Woods Jr. V.L. |
| |
|
HETEROZYGOUS FIBRINOGEN GAMMA-375 ARG-TRP MUTATION ASSOCIATED WITH EXCESSIVE SIALYLATION, PLASMIN RESISTANCE AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
|
| Morris T.A., Magana M.M., Marsh J.J., Chiles P.G., DeSantis D.J., Gruppo R.A., Woods Jr. V.L. |
| |
|
HFE GENE MUTATIONS DO NOT SHOW ASSOCIATIONS WITH HEMOPHILIC ARTHROPATHY
|
| Gomperts E.D., Lail A., McKenzie L., Donfield S., Winkler C. |
| |
|
HIGH ABSOLUTE RISKS AND PREDICTORS OF VENOUS AND ARTERIAL THROMBOEMBOLIC EVENTS IN PATIENTS WITH NEPHROTIC SYNDROME
|
| Mahmoodi B.K., ten Kate M.K., Waanders F., Veeger N.J.G.M., Navis G.J., van der Meer J. |
| |
|
HIGH CONCENTRATION OF PROCOAGULANT PHOSPHOLIPIDS AND THROMBOMODULIN ACTIVITY ARE FOUND IN PREGNANCY COMPLICATIONS
|
| Van Dreden P., Fontaine S., Rousseau A., Woodhams B.J. |
| |
|
HIGH D-DIMER LEVEL INCREASES THE LIKELIHOOD OF PULMONARY EMBOLISM IN A HIGH-RISK POPULATION
|
| Hovens M.M.C., Nijkeuter M., Tick L.W., Kramer M.H.H., Buller H.R., Leebeek F.W.G., Huisman M.V. |
| |
|
HIGH DOSE FACTOR VIIA CORRECTS THROMBIN GENERATION IN A MODEL OF DILUTIONAL COAGULOPATHY
|
| Stuckey A., Ezban M., Hedner U., Hoffman M., Roberts H.R., Monroe D.M. |
| |
|
HIGH DOSES OF RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN A HEMOPHILIA A PATIENT WITH INHIBITOR
|
| Berger C., Mattei J., Reynaud J., Thouvenin S., Jerome C., Stephan J. |
| |
|
HIGH GLUCOSE INHIBITS NITRIC OXIDE PRODUCTION THROUGH AN HYPEROSMOLAR EFFECT, WITHOUT INDUCING ENDOTHELIAL CELL ADHESION SURFACE EXPRESSION IN HUMAN ENDOTHELIAL CELLS
|
| Madonna R., Zurro M., Montebello E., Lazzerini G., De Caterina R. |
| |
|
HIGH INCIDENCE OF CLOPIDOGREL NON-RESPONSIVENESS IN PATIENTS WITH CORONARY ARTERY DISEASE A REAL WORLD SITUATION
|
| Schaefer A., Weinberger S., Eigenthaler M., Ertl G., Bauersachs J. |
| |
|
HIGH INSULIN IMPAIRS PI-3 KINASE/AKT-MEDIATED INSULIN SIGNALING IN HUMAN ENDOTHELIAL CELLS: AN IN VITRO INDUCTION OF INSULIN RESISTANCE?
|
| Madonna R., De Caterina R. |
| |
|
HIGH LEVELS OF LDL-CHOLESTEROL AND TRIGLYCERIDES AND SUBOPTIMAL GLYCEMIC CONTROL PREDICT DIMINISHED EX VIVO ASPIRIN RESPONSIVENESS IN PATIENTS WITH TYPE 2 DIABETES
|
| Hovens M.M.C., Snoep J.D., Groeneveld Y., Eikenboom J.J., Tamsma J.T., Huisman M.V. |
| |
|
HIGH NOREPINEPHRINE LEVEL IS ASSOCIATED WITH SIGNIFICANT PLATELET HYPERREACTIVITY DEMONSTRATED BY INCREASED PLATELET P-SELECTIN POSITIVITY, ADENOSIN DIPHOSPHATE AND COLLAGEN INDUCED AGGREGATIONS IN STABLE CORONARY HEART DISEASE PATIENTS ON DUAL ANTIPLATEL
|
| Béres B.J., Tóth-Zsámboki E., Vargová K., Kiss N., Kovács A., Husvéth Á., László Á., Masszi T., Préda I., Kiss R.G. |
| |
|
HIGH PREVALENCE OF ELEVATED FACTOR VIII IN IRANIAN PATIENT WITH IDIOPATHIC VENOUS THROMBOEMBOLISM
|
| Tabatabaei S., Azarkeyvan A., Ahmadinejad M., Tavasoli F., Sajadi S., Jalali Far M. |
| |
|
HIGH PREVALENCE OF IRON DEFICIENCY AMONG PATIENTS REFERRED FOR EVALUATION OF A BLEEDING DISORDER
|
| Pai M., Liu Y., Whittaker S., Arnold E., Seecharan J., Moffat K., Webert K., Heddle N., Hayward C.P.M. |
| |
|
HIGH PROPORTION OF MATERNAL THROMBOPHILIA AMONG PREVIOUSLY UNEXPLAINED STILLBIRTH CASES
|
| Kedem A., Ofir K., Moran O., Schiff E., Simchen M.J. |
| |
|
HIGH RESOLUTION IMAGING OF PLATELETS IN VITRO AND IN VIVO
|
| Jackson S.P., Westein E., Nesbitt W.S. |
| |
|
HIGH RISK FOR VENOUS THROMBOEMBOLISM IN DIABETICS WITH HYPEROSMOLAR STATE: COMPARISON WITH OTHER ACUTE MEDICAL ILLNESSES
|
| White R.H., Keenan C., Murin S., Zhou H. |
| |
|
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) AND THE RISK OF FIRST EVER ISCHEMIC STROKE IN HEALTHY PEOPLE
|
| Masotti L., Landini G., Cappelli R. |
| |
|
HIGH SENSITIVITY THROMBOGENIC MARKER DETECTION IN THE INTRALUMINAL BOUNDARY LAYER
|
| Tucker E.I., Marzec U.M., Gruber A., Hanson S.R. |
| |
|
HIGH-AFFINITY GLUTAMATE TRANSPORTERS OF BLOOD PLATELETS AS POTENTIAL PERIPHERAL MARKERS TO ANALYZE GLUTAMATE TRANSPORT ACTIVITY IN BRAIN
|
| Borisova T.A., Kasatkina L. |
| |
|
HIGHER FIBRIN MONOMERS (FM) LEVELS AFTER ORAL ANTICOAGULATION (OAT) WITHDRAWAL ARE ASSOCIATED WITH INCREASED RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE
|
| Legnani C., Cosmi B., Cini M., Mattarozzi S., Palareti G. |
| |
|
HIGH-MOBILITY GROUP BOX 1 PROTEIN PROMOTES DEVELOPMENT OF MICROVASCULAR THROMBOSIS IN RATS
|
| Ito T., Kawahara K., Hashiguchi T., Maruyama I. |
| |
|
HIGH-THROUGHPUT MULTIPLEX SINGLE-NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS IN GENES INVOLVED IN METHIONINE METABOLISM
|
| Giusti B., Sestini I., Saracini C., Sticchi E., Bolli P., Evangelisti L., Lapini I., Prisco D., Gensini G.F., Abbate R. |
| |
|
HIGH-YIELD PRODUCTION AND CHARACTERIZATION OF RECOMBINANT APROTININ IN SACCHAROMYCES CEREVISIAE
|
| Meta A., Nakatake H., Imamura T., Nozaki C. |
| |
|
HISTIDINE-RICH GLYCOPROTEIN (HRG) MODULATES THE FUNCTION OF FXII IN HEMOSTASIS
|
| MacQuarrie J.L., Fredenburgh J.C., Stafford A.R., Weitz J.I. |
| |
|
HIT II-INDUCED CRITICAL LIMB ISCHAEMIA TREATED WITH UROKINASE AND ARGATROBAN
|
| Beyer J., Gehrisch S., Leonhard J., Weise M., Schellong S. |
| |
|
HMGB1 PLAYS A CENTRAL ROLE IN ATHEROTHROMBOSIS
|
| Maruyama I., Kawahara K., Ito T., Oyama Y., Hashiguchi T., Inoue K. |
| |
|
HOME CLINICAL ASSISTANCE: SICILIAN SURVEY ON THE HCA SUPPORT FOR THE MANAGEMENT OF THE PROPHYLAXIS IN PAEDIATRIC HAEMOPHILIAC PATIENTS
|
| Mancuso G., Gagliano F., Bruno G., Rizzo M., Mansueto M. |
| |
|
HOME TREATMENT WITH RECOMBINANT VIIA FACTOR IN HEMOPHILIA PATIENTS WITH INHIBITOR
|
| Vdovin V.V., Plyushch O.P., Zozulya N.I., Kopylov K.G. |
| |
|
HOMOCYSTEINE AND ITS THIOLACTONE DERIVATIVE ACTIVATE THE PLATELET INTEGRIN ALPHA IIB BETA 3
|
| McGarrigle S.A., Leong T., Cooney M.T., O'Neill S., Moran N., Graham I.M., Collins P.B. |
| |
|
HOMOCYSTEINE AND RISK FOR VENOUS THROMBOSIS IN A POPULATION-BASED PROSPECTIVE STUDY (HUNT2)
|
| Næss I.A., Christiansen S.C., Romundstad P.R., Cannegieter S.C., Rosendaal F.R., Hammerstrøm J. |
| |
|
HOMOCYSTEINE AS INDICATOR OF OSTEOPOROSIS. THE INCHIANTI STUDY
|
| Corsi A., Lauretani F., Bandinelli S., Gori A., Fedi S., Ferrucci L., Abbate R. |
| |
|
HOMOCYSTEINE INDUCES VCAM-1 GENE EXPRESSION THROUGH NF-KB AND NAD(P)H OXIDASE ACTIVATION: PROTECTIVE ROLE OF MEDITERRANEAN DIET POLYPHENOLIC ANTIOXIDANTS
|
| Carluccio M.A., Massaro M., Carluccio M., Scoditti E., Distante A., Storelli C., De Caterina R. |
| |
|
HOMOCYSTEINE LEVELS AND PREVALENCE OF C677T POLYMORPHISM IN METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) GENE IN CHILDREN WITH MIGRAINE
|
| Katsadze Y.L., Tadtaeva Z.G., Papayan K.A., Shmeleva V.M. |
| |
|
HOMOCYSTEINE PLASMA LEVELS AND MTHFR C677T MUTATION IN PATIENTS WITH CORONARY ARTERIAL DISEASE, ISCHEMIC STROKE AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE
|
| Sabino A.P., Carvalho M.G., Ribeiro D.D., Lima L.M., Santos E.R.C., Sousa M.O., Domingheti C.P., Dusse L.M.S., Fernandes A.P.S.M. |
| |
|
HOMOCYSTINURIA AND CARDIOVASCULAR MANIFESTATIONS: 5 ITALIAN CASES
|
| Evangelisti L., Attanasio M., Lucarini L., Rossi L., Lapini I., Lenti M., Prisco D., Abbate R., Gensini G.F., Pepe G. |
| |
|
HOMOZYGOUS FACTOR V DEFICIENCY WITH MILD CLINICAL PHENOTYPE
|
| Hewitt J., Talbot K., Song J., Ho M., Pryzdial E.L.G., MacGillivray R.T.A., Carter C.J. |
| |
|
HOMOZYGOUS FOUR-BASE DELETION TGAG IN THE GLYCOPROTEIN IBA CODING SEQUENCE LEADING TO A PREMATURE STOP CODON IN A PATIENT WITH BERNARD-SOULIER SYNDROME
|
| Vettore S., Scandellari R., Scapin M., Scarparo P., Randi M., Fabris F. |
| |
|
HOSPITALISATION FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD- IS IT ALWAYS NECESSARY?
|
| Martinova K., Muratovska O., Glamocanin S., Antevska Z. |
| |
|
HOT TOPIC DEFECTIVE ACTIVATION OF PLATELET INTEGRINS IN TALIN-DEFICIENT MICE
|
| Nieswandt B., Moser M., Pleines I., Pozgajova M., Critchley D.R., Fässler R. |
| |
|
HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
|
| Gallinaro L., Cattini M., Bertomoro A., Pontara E., Sartorello F., Soldera C., Padrini R., Pagnan A., Casonato A. |
| |
|
HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
|
| Gallinaro L., Cattini M., Bertomoro A., Pontara E., Sartorello F., Soldera C., Padrini R., Pagnan A., Casonato A. |
| |
|
HOW TO EFFECTIVELY MEASURE THE INHIBITION OF THROMBOXANE GENERATION BY ASPIRIN IN WHOLE CITRATED BLOOD?
|
| Watala C.W., Golanski J.A., Golanski R., Kuliczkowski W. |
| |
|
HOW TO ESTIMATE BLEEDING RISK IN MILD BLEEDING DISORDERS
|
| Rodeghiero F., Tosetto A., Castaman G. |
| |
|
HUMAN MALIGNANT CELLS EXPRESS FUNCTIONALLY ACTIVE ENDOTHELIAL PROTEIN C RECEPTOR
|
| Ducros E., Darvishi S., Mirshahi S.S., Rafii Tabrizi A., Soria J., Mirshahi M. |
| |
|
HUMAN PLATELETS AND MEGAKARYOCYTES CONTAIN FACTOR X mRNA, DETECTED WITH REAL-TIME QUANTITATIVE RT-PCR
|
| Holme P.A., Fløisand Y., Bjerkeli V., Bjørnsen S., Brosstad F. |
| |
|
HUMAN PLATELETS CIRCULATING IN MICE: APPLICATIONS FOR INTERROGATING PLATELET FUNCTION AND SURVIVAL, THE EFFICACY OF ANTI-PLATELET THERAPEUTICS, AND THE MOLECULAR BASIS OF PLATELET IMMUNOLOGICAL DISORDERS
|
| Newman P.J., Aster R., Boylan B. |
| |
|
HUMAN PROTEIN Z GENE EXPRESSION IS REGULATED BY HNF-4ALPHA AND SP1, INDEPENDENT OF WARFARIN AND VITAMIN K
|
| Sugawara H., Iwata H., Souri M., Ichinose A. |
| |
|
HUMAN TISSUE KALLIKREINS, HK6 AND HK10 AS NOVEL BIOMARKERS FOR EPITHELIAL OVARIAN CANCER
|
| Razvi K., Koh S.C.L., Loganath A., Narasimhan K., Ilancheran A., Choolani M. |
| |
|
HUMAN VASCULAR ENDOTHELIAL CELLS INFLUENCE THE WHOLE BLOOD THROMBIN GENERATION ASSAY
|
| Tappenden K.A., Evans G., Gallimore M.J., Mackie I.J., Wendel H.P., Winter M., Jones D.W. |
| |
|
HUMAN VH1-69 GERMLINE GENE ENCODED ANTI-SPACER DOMAIN ANTIBODIES THAT DEVELOP IN PATIENTS WITH ACQUIRED TTP INTERFERE WITH THE BINDING OF ADAMTS13 TO VWF
|
| Pos W., Luken B.M., Turenhout E.A.M., Kremer Hovinga J.A.K., Aboulfatova K., Dong J., Fijnheer R., Voorberg J. |
| |
|
HYDRAULIC FIRMNESS OF NATIVE CLOT IN HUMAN VESSEL: MODEL EXPERIMENTS
|
| Savushkin A.V. |
| |
|
HYDROXYTYROSOL, THE MAJOR OLIVE OIL PHENOLIC ANTIOXIDANT, REGULATES EXPRESSION AND ACTIVITY OF MATRIX METALLOPROTEINASE(MMP)-9 IN HUMAN MONOCYTOID CELLS - POSSIBLE CONTRIBUTION TO PLAQUE STABILITY
|
| Carluccio M.A., Nestola A., Massaro M., Scoditti E., Distante A., Storelli C., De Caterina R. |
| |
|
HYPERACTIVE C-JUN N-TERMINAL KINASE ENHANCES VASCULAR TISSUE FACTOR EXPRESSION IN AGING
|
| Carvas J.M., Barandier C., Xiu-Fen M., Yang Z. |
| |
|
HYPERCHOLESTEROLEMIA IS STRONGLY ASSOCIATED WITH RISK OF RECURRENT VTE IN WOMEN TREATED FOR 5-7 MONTHS WITH ORAL ANTICOAGULANTS (OAC) FOR IDIOPATHIC VENOUS THROMBOEMBOLISM (VTE)
|
| Rodger M.A., Kovacs M.J. |
| |
|
HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS
|
| Francis J.L., Bigsby G., Desai H., Amaya M., Coll E., Robles L., Drexler A., Faust P., Langer F., Reyes E., Amirkhosravi A. |
| |
|
HYPERCOAGULABLE STATE IN MULTIPLE MYELOMA PATIENTS TREATED OR NOT WITH THALIDOMIDE
|
| Petropoulou A.D., Gerotziafas G.T., Rendu F., Samama M.M., Elalamy I. |
| |
|
HYPERFIBRINOLYTIC STATE IN ACUTE PROMYELOCYTIC LEUKEMIA ASSOCIATED WITH DISSEMINATED INTRAVASCULAR COAGULATION
|
| Wang Z., Zhang W., Xie Y., Ruan C. |
| |
|
HYPERGLYCAEMIA AND DYSLIPIDAEMIA ARE NOT SUFFICIENT TO INDUCE PLATELET HYPERACTIVITY IN THE DIABETIC APOLIPOPROTEIN E-/- MOUSE
|
| Calkin A.C., Gordon M.V., Ono A., Gatt A.M., Schoenwaelder S.M., Cooper M.E., Jackson S.P. |
| |
|
HYPERGLYCEMIA ACCELERATES ARTERIAL THROMBUS FORMATION AND ATTENUATES THE ANTITHROMBOTIC RESPONSE TO ENDOTOXIN IN MICE
|
| Spronk H.M.H., Hansen H.R., Wolfs J.L., Sommeijer D.W., Bruggemann L.W., Beevers E.M., Spek C.A., Reitsma P.H., ten Cate H. |
| |
|
HYPERHOMOCYSTEINEMIA AND FACTOR V LEIDEN ACT SYNERGISTICALLY INCREASING RISK OF VEIN THROMBOSIS IN NORTH-WESTERN RUSSIA
|
| Shmeleva V.M., Kapustin S.I., Dremov R.I., Larionov A.A., Chernookov A.I. |
| |
|
HYPERHOMOCYSTEINEMIA AND THROMBOSIS: THE DIAGNOSTIC ROLE OF POST METHIONINE-LOAD TEST
|
| Durante C., Boschian B. R., Pivetta F., Poles O., Zanolin S., De Marco L., Steffan A. |
| |
|
HYPERHOMOCYSTEINEMIA AND VENOUS THROMBOSIS IN BELARUS
|
| Gusina A.A., Gusina N.B., Zatsepin I.O., Baeshko A.A., Naumchic I.V. |
| |
|
HYPERHOMOCYSTEINEMIA IS ASSOCIATED WITH APC RESISTANCE
|
| Binetti B.M., Martinelli I., Cattaneo M., Semeraro N., Colucci M. |
| |
|
HYPERHOMOCYSTEINEMIA IS NOT A RISK FACTOR FOR VENOUS AND ARTERIAL THROMBOSIS, BUT AN EPIPHENOMENON: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY
|
| Lijfering W.M., Coppens M., Veeger N.J.G.M., Middeldorp S., Hamulyák K., Prins M.H., Büller H.R., van der Meer J. |
| |
|
HYPERHOMOCYSTEINEMYA IS COMMON IN ACUTE CORONARY SYNDROMES IN NORTH-WESTERN RUSSIA
|
| Smirnova O.A., Shmeleva V.M., Golovina O.G., Silina N.N., Boldueva S.A., Papayan L.P. |
| |
|
HYPERREACTIVE PLATELETS IN PATIENTS WITH GS DEFICIENCY
|
| Freson K., Labarque V., Thys C., Wittevrongel C., Jaeken J., Van Geet C. |
| |
|
HYPERVISCOSITY AS A POSSIBLE DETERMINANT OF INFARCT SIZE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
|
| Cecchi E., Alessandriello Liotta A., Gori A.M., Valente S., Giglioli C., Lazzeri C., Sofi F., Gensini G.F., Abbate R., Mannini L. |
| |
|
HYPOFIBRINOLYSIS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION IN MEN
|
| Meltzer M.E., Doggen C.J.M., de Groot P.G., Rosendaal F.R., Lisman T. |
| |
